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Abstract 
A collaborative exercise on DNA methylation-based body fluid identification was conducted 
by seven laboratories. For this project, a multiplex methylation SNaPshot reaction composed 
of seven CpG markers was used for the identification of 4 body fluids, including blood, 
saliva, semen and vaginal fluid. A total of 30 specimens were prepared and distributed to 
participating laboratories after thorough testing. The required experiments included four 
increasingly complex tasks: 1) capillary electrophoresis of a purified single-base extension 
reaction product, 2) multiplex PCR of bisulfite-modified DNA, 3) bisulfite conversion of 
genomic DNA and 4) extraction of genomic DNA from body fluid samples. In tasks 2, 3 and 
4, one or more mixtures were analyzed, and specimens containing both known and unknown 
body fluid sources were used. Six of the laboratories generated consistent body fluid typing 
results for specimens of bisulfite converted DNA and genomic DNA. One laboratory failed to 
set up appropriate conditions for capillary analysis of reference single-base extension 
products. In general, variation in the values obtained for DNA methylation analysis between 
laboratories increased with the complexity of the required experiments. However, all 
laboratories concurred on the interpretation of the DNA methylation profiles produced. 
Although the establishment of interpretational guidelines on DNA methylation-based body 
fluid identification has yet to be performed, this study supports the addition of DNA 
methylation profiling to forensic body fluid typing. 
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1. Introduction  
 
Body fluid identification can be of significant importance in solving crimes by assisting the 
triers of fact in the determination of potential scenarios that may have led to the deposition of 
evidentiary material [1]. Recently, molecular approaches that permit the detection of specific 
messenger RNA (mRNA) and micro RNA (miRNA) expression as well as differential DNA 
methylation patterns have been intensively investigated [2]. Among these, the mRNA-based 
detection methods have been the most scrutinized, and performance in terms of 
reproducibility and sensitivity has been well evaluated through a series of large collaborative 
exercises [2–8].  
DNA methylation-based body fluid identification has many advantages when compared 
to mRNA-based methods, such as higher specificity, the ability to be inserted into current 
forensic DNA-based testing protocols, and the applicability to old cases where only DNA 
extracts are available [9]. Many CpG markers have been identified which produce differential 
DNA methylation patterns when extracted DNA from body fluids are compared using 
genome-wide profiling and gene-specific analysis [10–15]. Three recent publications [13–15] 
are particularly notable for reporting a set of CpG markers that show a methylation signal 
only in the target body fluids, which can be beneficial to mixed sample analysis. In particular, 
two earlier studies [13, 14] reported two markers in common; cg17610929, suggested to 
distinguish semen and cg06379435, for blood. Moreover, further analysis of array data from 
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the two studies revealed that they had another blood-specific marker, cg08792630, in 
common. Because the identification and use of semen-specific CpG markers is not a problem 
due to the significant difference in DNA methylation between somatic cells and germ cells, 
further validation studies of CpGs specific to other body fluids, such as vaginal fluid, 
menstrual blood, saliva etc., would be needed for better application of DNA methylation 
analysis in forensic caseworks. To detect DNA methylation levels at multiple CpG sites 
simultaneously, methylation-sensitive restriction enzyme-PCR (MSRE-PCR) and the 
methylation-sensitive single nucleotide primer extension (SNuPE)-based approach, generally 
called methylation SNaPshot, have been utilized [10, 14, 15]. In comparison to MSRE-PCR, 
methylation SNaPshot reactions provide better resolution, and have been adopted in more 
recent studies [14–16]. 
The present collaborative exercise was organized by Yonsei University College of 
Medicine in order to evaluate the robustness and reproducibility of DNA methylation 
profiling for body fluid identification in seven forensic laboratories using kits and chemistries 
of their own choice and using their own instrumentation. The multiplex methylation 
SNaPshot reaction used by the collaborative laboratories described in [14] was modified to 
include seven CpG markers that show a methylation signal only in the target body fluids. 
Since the participating laboratories had varying levels of experience, especially with DNA 
methylation profiling using bisulfite conversion and with the SNaPshot reaction, the goal was 
to implement the method and compare the interpretational results of DNA methylation 
profiling from the various laboratories.  
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2. Materials and methods 
 
2.1 Samples and materials provided 
 
The exercise was divided into four parts such that participants could easily check the success 
of experiments performed after each step of the consecutive procedures (Table 1). Part 1 
involved the capillary electrophoresis of purified single-base extension (SBE) reaction 
products, part 2 involved multiplex PCR of bisulfite converted DNA, part 3 involved the 
bisulfite conversion of genomic DNA and part 4 involved the DNA extraction of body fluid 
samples. As such, the complexity of the required experiments increased as the participants 
proceeded through each part. Specimens, including blood, saliva, semen, vaginal fluid, and 
menstrual blood, were collected from seven healthy volunteers using procedures approved by 
the Institutional Review Board of Severance Hospital, Yonsei University in Seoul, Korea. 
Blood was collected by venipuncture with a syringe, and 200 μL aliquots from EDTA 
containing tubes were stored frozen at -20˚C. Saliva samples were collected with the 
Oragene™ DNA self-collection kit (DNA Genotek Inc., Ottawa, Canada), and stored at 
ambient temperature. Freshly ejaculated semen was collected in plastic cups, and 200 μL 
aliquots were frozen at -20˚C for storage. Vaginal fluid and menstrual blood were collected 
using sterile cotton swabs and allowed to dry at room temperature. The eight body fluid 
specimens used in part 4 included four single source samples and one mixture of indicated 
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origin, and two single source samples and one mixture of unspecified origin. One hundred 
and twenty microliter of freshly ejaculated semen and blood were prepared separately in an 
eppendorf microfuge tube with indicated origin. A 200 μL of saliva sample was prepared in 
the Oragene™ DNA self-collection kit buffer with indicated origin. Two vaginal swabs and a 
menstrual blood swab were obtained from a volunteer. From the two vaginal swabs obtained 
from a volunteer, one was spiked with 70 μL of semen and both were provided to the 
collaborative laboratories with an indication of their origin. The menstrual blood swab was 
sent to the collaborative laboratories with unspecified origin. A semen swab was prepared by 
dropping 100 μL of semen on a sterile cotton swab, and was provided to the collaborative 
laboratories with unspecified origin. A body fluid mixture swab was prepared by adding 100 
μL solution of blood, saliva and semen mixed in a ratio of 2:1:1.5 on a sterile cotton swab 
and was provided to the collaborative laboratories with unspecified origin. Treated swabs 
were allowed to dry at room temperature and stored at -80˚C until sent to participating 
laboratories.  
For parts 2 and 3, 100 ng of bisulfite converted DNA and 200 ng of genomic DNA were 
prepared for five single source samples with an indicated source of origin, two single source 
samples of unspecified origin, and one mixture of unspecified origin. To prepare mixtures in 
parts 2 and 3, the same concentration of each bisulfite converted DNA (from blood and 
saliva) or genomic DNA (from semen and vaginal fluid) were mixed in a ratio of 1:1.  
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For part 1, the final products from the methylation SNaPshot reaction obtained from one 
sample each of semen, blood, vaginal fluid and saliva, and two samples from menstrual 
bloods were prepared as reference materials.  
All samples and PCR primer mixtures were thoroughly tested prior to shipment and sent 
to participating laboratories on dry ice taking from one to four days. When requested, 
additional reagents such as SNaPshot kit (Applied Biosystems, Foster City, CA, USA) or 
enzymes necessary for PCR product purification, SBE reaction and purification were sent 
together on dry ice, and the Imprint™ DNA Modification kit (Sigma-Aldrich, St. Louis, MO, 
USA) for bisulfite conversion was sent at room temperature. 
 
2.2 DNA extraction, DNA quantification and bisulfite conversion 
 
In the organizing laboratory, samples were subjected to DNA extraction, quantification and 
sodium bisulfite treatment. DNA was extracted from each aliquot of blood, saliva, and semen 
or from each swab of vaginal fluid and menstrual blood using a QIAamp® DNA Mini kit 
(Qiagen, Hilden, Germany) following the manufacturer’s instructions. Extracted DNA was 
quantified using a Quantifiler
®
 Duo DNA Quantification kit (Applied Biosystems), and 200 
ng of genomic DNA was bisulfite converted using the Imprint™ DNA Modification kit and 
eluted with 20 μL of distilled water. For preparation of specimens to send to collaborative 
laboratories, an appropriate number of genomic DNA and bisulfite converted DNA batches 
were pooled and redistributed into 10 μL aliquots, which contained 20 ng/μL of genomic 
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DNA or approximately 10 ng/μL of bisulfite converted DNA. The specified genomic DNA 
input in bisulfite conversion of part 3 was 100 ng of genomic DNA, but in part 4, the input 
amount was not suggested. Example protocols were provided to participating laboratories 
(Supplementary Material 1) as a reference, but the chemistries and instrumentation to be used 
were left for each laboratory to decide.  
 
2.3 Multiplex methylation SNaPshot 
 
The multiplex methylation SNaPshot reaction described in [14] was modified to include 
seven CpG markers that show a methylation signal only in the target body fluids. For this 
study, a blood marker, cg01543184, with cross reactivity to semen was replaced with blood 
marker cg08792630 [13], and a semen marker cg17621389 with that produced semen-
specific non-methylation was removed. The resultant multiplex included two CpGs (SE1 and 
SE2) for semen, two CpGs (BL1 and BL3) for blood, two CpGs (VF1 and VF2) for vaginal 
fluid and one CpG (SA1) for saliva (Supplementary Material 1); SE1, SE2, BL1, BL3, VF1, 
VF2, and SA1 represent cg17610929, cg26763284, cg06379435, cg08792630, cg09765089-
231d, cg26079753-7d, and cg09652652-2d, respectively. The multiplex PCR was performed 
in 20 μL reactions containing 1 μL of bisulfite-converted DNA (10 ng), 3 U of AmpliTaq 
Gold
®
 DNA polymerase, 2 μL of Gold ST*R 10× buffer (Promega, Madison, WI, USA), and 
PCR primers (Supplementary material 1). PCR cycling was conducted using a Veriti™ 
Thermal Cycler (Applied Biosystems) under the following conditions: 95˚C for 11 min; 34 
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cycles of 94˚C for 20 s, 56˚C for 60 s, and 72˚C for 30 s; and a final extension at 72˚C for 7 
min. Then, 5 μL of PCR products were purified with 1 μL of ExoSAP-IT (USB, Cleveland, 
OH, USA) by incubation at 37˚C for 45 min followed by heat inactivation at 80˚C for 15 min. 
Multiplex SBE reaction was performed using 1 μL of purified PCR products, SBE primers 
(Supplementary Material 1) and a SNaPshot
TM
 kit according to the manufacturer’s 
instructions. The final extension products were purified with SAP-Recombinant (USB) 
enzyme. Large batch of 5× PCR primer and 10× SBE primer stocks were prepared and 
aliquoted to provide all laboratories with the same primer mixtures. The specified bisulfite 
converted DNA input for the multiplex PCR of parts 2 and 3 was 10 ng; in part 4, the input 
amount was not suggested. Example protocols were provided to participating laboratories 
(Supplementary Material 1), but a choice was given regarding which PCR buffers and 
amplicon purification methods were to be used.  
 
2.4 Capillary electrophoresis and analysis of DNA methylation profiles 
 
In the organizing laboratory, the extension products were analyzed using the ABI PRISM 
3130xl Genetic Analyzer and GeneScan software 3.1 (Applied Biosystems). In participating 
laboratories, samples were injected and run according to conditions of choice on various 
types of standard genetic analyzers (Supplementary material 2). For the analysis of DNA 
methylation profiles, participating laboratories were requested to report peak heights 
observed from the electropherograms and to calculate percentage methylation values (0–
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100%) at each CpG site by dividing nucleotide G intensity (detection of unconverted 
methylated cytosine on the reverse strand) by nucleotide G plus nucleotide A intensity 
(detection of converted unmethylated cytosine on the reverse strand). Then, body fluid typing 
results were reported in reference to the electrophoretic results of SBE products in part 1.  
 
3. Results and Discussion  
 
3.1. Participating laboratories 
 
Seven laboratories including the organizing laboratory participated in this exercise. The 
participating laboratories varied in experience with regard to DNA methylation analyses. 
Two laboratories indicated they were beginners at DNA methylation testing; two other 
laboratories, advanced beginners; one laboratory, an experienced researcher; and two other 
laboratories, experts. The participating laboratories were also asked to complete a 
questionnaire describing the kits, chemicals, quantities and instrumentation they used 
(Supplementary material 2). The seven laboratories used four different kits for DNA 
extraction, five different quantification methods, two different kits for bisulfite conversion, 
two different PCR buffers for multiplex PCR, three different thermocyclers, three different 
genetic analyzers and three different analytical software and five different analytical settings. 
The diversity of instrumentation and respective analysis tools emphasizes the importance of 
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such collaborative exercises in order to evaluate the robustness of implementation of methods 
in different laboratories. 
 
3.2. Exercise tasks: parts 1 to 4 
 
The collaborative exercise started with part 1, where purified SBE products are analyzed 
with capillary electrophoresis. Analysis of the final multiplex methylation SNaPshot products 
from various body fluid samples provided references to the following data interpretation and 
enabled adjustment of the genetic analyzer setting if necessary. Six of the seven laboratories 
reported very similar results in part 1 (Fig. 1). One laboratory (laboratory 4) had, on average, 
4-fold higher peaks than the organizing laboratory with low non-specific peaks that seemed 
to be due to the use of higher injection settings. Because of failure in adjusting the genetic 
analyzer setting and unsuccessful enzyme treatment to purify PCR products in the subsequent 
parts 2–4 at laboratory 4, the results discussed in this report will only include data from the 
remaining six laboratories. The methylation percentages at each CpG site were similar among 
the laboratories, but two laboratories using an ABI PRISM 310 genetic analyzer showed 
somewhat lower methylation percentages. In addition, it seems that because two types of 
menstrual blood of which one had the same profile as vaginal fluid (menstrual blood type 1) 
were provided as references in part 1, participating laboratories had difficulty in inferring the 
sample origin with the profile of vaginal fluid; in this case, some laboratories reported the 
origin of the sample to be either vaginal fluid or menstrual blood, while others reported it to 
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be vaginal fluid or menstrual blood (Supplementary Material 3). As such, a distinction 
between vaginal fluid and menstrual blood could not be provided for the reports regarding 
parts 2–4.  
In part 2, bisulfite converted genomic DNA of semen, blood, vaginal fluid, menstrual 
blood and saliva with known body fluid origin, and three other samples with unspecified 
origin of which two were single source and one was a mixture, allowed us to test the 
proficiency of the participating laboratories in performing the SNaPshot reaction. Four of the 
six laboratories reported methylation signals only at target body fluid-specific CpG markers 
with correct body fluid typing results (Fig. 2). Two laboratories reported additional low level 
methylation signals at SE1, BL1 and SA1 markers, but these results did not affect correct 
interpretation of the body fluid typing results (Supplementary Material 3). These signals had 
low methylation percentages, mostly less than 15%. For example, the two lowest methylation 
signals from laboratory 6 were 100 rfu and 94 rfu corresponding to 6.7% and 8.1% 
methylation percentages at BL1 and SA1 CpG sites, respectively. Therefore, all six 
laboratories properly performed and implemented the multiplex SNaPshot reactions with 10 
ng of bisulfite converted DNA.  
For part 3, genomic DNA from semen, blood, vaginal fluid, menstrual blood and saliva 
and three genomic DNA samples of unspecified origin were provided to test each 
laboratory’s proficiency in bisulfite conversion. The participating laboratories were asked to 
treat 100 ng of genomic DNA with a bisulfite conversion kit of choice and to perform 
multiplex methylation SNaPshot reactions with a 1/10 portion of the eluted bisulfite 
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converted DNA. Two kits were used in bisulfite conversion (Supplementary material 2), but 
no significant difference was observed between the results. As in part 2, the same four 
laboratories reported methylation signals only at target body fluid-specific CpG markers with 
correct body fluid typing results (Fig. 3). Two laboratories (laboratories 5 and 6) reported 
sporadic methylation signals at the BL1 or BL3 markers in semen, menstrual blood and in the 
mixture of semen and vaginal fluid. These peaks were generally low in methylation 
percentage, i.e. less than 15%, and did not affect the correct interpretation of body fluid 
typing results. However, the methylation percentages at each target CpG site showed higher 
variation among laboratories in part 3 when comparing to parts 1 and 2. Laboratory 3 
reported no signal at the BL3 marker in a sample that was most likely a result of PCR failure 
at this site; however, it did not affect the identification of body fluid type. In addition, 
laboratory 6 reported a high methylation percentage (35.6%) at the BL1 site in the mixture of 
semen and vaginal fluid, leading to a body fluid typing result of a mixture of semen and 
menstrual blood (Supplementary Material 3). In most cases, laboratories concurred on the 
expected interpretation of the results reported among them with genomic DNA and bisulfite 
converted DNA. This result suggests that DNA methylation-based body fluid identification 
using multiplex methylation SNaPshot and bisulfite conversion of genomic DNA could be 
successfully incorporated into forensic laboratory workflow. 
In part 4, various body fluid samples with and without specified origin were provided. 
Specimens were subjected to DNA extraction, quantification, bisulfite conversion and 
multiplex methylation SNaPshot reaction using various methodologies according to each 
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laboratory’s preference. Three DNA extraction kits and four quantification methods were 
used by the six different laboratories. Sufficient amounts of DNA were obtained from most of 
the laboratories, but relatively small yields of DNA were obtained in one of the laboratories 
using an automatic DNA extraction system (laboratory 6). Various amounts of DNA were 
subjected to bisulfite conversion and 1/10 or 1/20 of the volume of eluted bisulfite converted 
DNA was amplified in a subsequent multiplex methylation SNaPshot reaction. The resultant 
amplified bisulfite converted DNA varied in amount from 0.8 ng to 20 ng. Of the six 
laboratories being evaluated, five laboratories produced acceptable results with the correct 
body fluid identification. The sixth laboratory (laboratory 5) failed to obtain electrophoretic 
results from a few specimens but produced correct results from the others (Supplementary 
Material 3). The five laboratories reported methylation signals only at target body fluid-
specific CpG markers except for a menstrual blood swab with unspecified origin (Fig. 4). For 
this sample, laboratory 6 produced unexpected methylation signals at SE1 and BL1 CpG 
markers, and laboratory 7 showed methylation signals at BL1 and BL3 CpG markers. 
However, these methylation signals were all less than 10%, and had no adverse effect on data 
interpretation since both laboratories reported the specimens to be either vaginal fluid or 
menstrual blood. Laboratory 5 did not get body fluid typing results from three samples with 
indicated origin. Since certain amounts of DNA were extracted and quantified from these 
three samples, failure seems to have occurred in the recovery of bisulfite converted DNA or 
in PCR amplification. This laboratory also reported “inconclusive” for a mixture swab with a 
methylation signal only at SE1, BL3 and SA1. However, additional low methylation signals 
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at SE2 and BL1 (~50 rfu) (data not shown) suggested the presence of semen, blood and saliva 
in this sample. In this exercise, the most experienced laboratories produced better DNA 
methylation profiles and interpretation results. However, even the laboratories that varied 
from less experienced to beginners in DNA methylation analysis produced successful body 
fluid typing results, providing strong evidence for the potential application of DNA 
methylation profiling for use in forensic body fluid typing.  
  
4. Concluding remarks 
 
This collaborative exercise aimed to examine the possibility of incorporating DNA 
methylation-based body fluid identification methods into forensic case-work workflow. Most 
of the participating laboratories reported consistent results for mixtures as well as for single 
source samples with the use of their own laboratory equipment and different kits and 
chemicals of choice, which demonstrate the usefulness of this application of DNA 
methylation profiling in forensic body fluid typing. In this study, we found that certain 
laboratories reported low but detectable methylation signals at unexpected CpG sites, and 
there were variations in DNA methylation percentages among laboratories. Because these 
unexpected methylation signals were frequently at less than 10% methylation and sometimes 
lower than 100 rfu, we recommend that in the future an appropriate detection threshold in 
terms of rfu and percent of methylation, e.g., more than 100 rfu and 10% methylation, should 
be applied. As for the methylation variation, this is not an unexpected result given that the 
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participating laboratories used a variety of methods and instrumentation. It is important to 
note that the seven CpGs used in this multiplex provide on-off signal variations in results that 
can alleviate the effect of methylation variation among laboratories. Because it is not possible 
to differentiate vaginal fluid and menstrual blood with the present multiplex methylation 
SNaPshot system, the addition of new menstrual blood-specific CpG markers to the multiplex 
system is needed for better identification of body fluids. In addition, with the use of two or 
more CpG markers for each target body fluid being preferred, it is evident that there is also a 
need to identify more CpGs that are specific to saliva. If possible, the multiplex system 
should be supplemented in the future with more CpG markers to have two or more CpGs for 
each body fluid and consequently increase the accuracy of the identification of body fluids. 
While routine use of DNA methylation-based body fluid typing and identification assays may 
yet require further tests for sensitivity and specificity, this study demonstrates that 
methylation profiling can be successfully implemented in forensic laboratories once clear 
guidelines are set for data interpretation.    
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Figure legends 
 
Figure 1. DNA methylation profiling results of part 1 conducted with the final SBE products 
of the multiplex methylation SNaPshot reaction. DNA methylation was recorded as a 
percentage value by dividing nucleotide G intensity by nucleotide G plus nucleotide A.  
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Figure 2. DNA methylation profiling results of part 2 conducted with bisulfite converted 
DNA. Part 2 results show the proficiency of each laboratory in SBE reaction analysis. (Un) 
indicates samples provided with unspecified body fluid origin. 
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Figure 3. DNA methylation profiling results of part 3 conducted with genomic DNA. Part 3 
results show the proficiency of each laboratory in bisulfite conversion. (Un) indicates 
samples provided with unspecified body fluid origin. 
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Figure 4. DNA methylation profiling results of part 4 with body fluid samples. Part 4 results 
show the proficiency of each laboratory in the entire DNA methylation-based body fluid 
typing procedure ranging from DNA extraction to capillary electrophoresis. (Un) indicates 
samples provided with unspecified body fluid origin.  
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Table 1. Overview of the samples and experiments required in each part of the collaborative exercise 1 
Part Samples  Required experiments 
1 
Purified
a
 SBE(single-base extension reaction) product
b
 
   6 samples : for each cell type
c
, single source samples,  
              cell type indicated 
Capillary electrophoresis 
2 
Bisulfite converted DNA
d
 
   5 samples : for each cell type
c
, single source samples,  
              cell type indicated  
   2 samples : single source samples, unspecified cell type  
    1 sample : mixture of two body fluids, unspecified cell type  
Multiplex PCR, Multiplex SBE,               
Capillary electrophoresis 
3 
Genomic DNA
e
 
   5 samples : for each cell type
c
, single source samples,  
              cell type indicated  
   2 samples : single source samples, unspecified cell type  
    1 sample : mixture of two body fluids, unspecified cell type  
Bisulfite conversion, 
Multiplex PCR, Multiplex SBE,                       
Capillary electrophoresis 
4 
Body fluid swabs 
   4 samples : for each cell type
f
, single source samples,  
              cell type indicated  
    1 sample : mixture of two body fluids, cell type indicated   
   2 samples : single source samples, unspecified cell type  
    1 sample : mixture of body fluids, unspecified cell type  
DNA extraction, DNA quantification,          
Bisulfite conversion, 
Multiplex PCR, Multiplex SBE,                       
Capillary electrophoresis 
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a 
Purified with SAP-Recombinant enzyme 
b
 Multiplex SBE reaction product 
c
 Semen, blood, vaginal fluid, menstrual blood and saliva 
d
 Bisulfite converted DNA using the Sigma’s Imprint
®
 DNA modification kit 
e
 Genomic DNA extracted using the Qiagen’s QIAamp DNA Mini kit and quantified using the ABI Quantifiler
®
 Duo DNA Quantification kit 
f
 Semen, blood, vaginal fluid and saliva 
 2 
